NBT Bank’s Lexicon Pharmaceuticals LXRX Stock Holding History

NBT Bank’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.6K	Hold	10,000	–	–	﹤0.01%	627
2025 Q4	$11.5K	Hold	10,000	–	–	﹤0.01%	653
2025 Q3	$13.5K	Hold	10,000	–	–	﹤0.01%	652
2025 Q2	$9.46K	Buy	+10,000	New	+$6.48K	﹤0.01%	657

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

NBT Bank's LXRX Position: Q1 2026 in Review

NBT Bank held its Lexicon Pharmaceuticals (LXRX) position steady in Q1 2026 at 10,000 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #627.

NBT Bank first reported a position in LXRX in Q2 2025 and has held it in 4 quarters since. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

NBT Bank held 10,000 shares of Lexicon Pharmaceuticals worth $15.6K as of Q1 2026.
NBT Bank left its Lexicon Pharmaceuticals share count unchanged in Q1 2026.
Lexicon Pharmaceuticals made up ﹤0.01% of NBT Bank's portfolio in Q1 2026, its #627 holding.
NBT Bank first reported a position in Lexicon Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.